Verampil
Verampil
- In Canada verampil (verapamil) is normally dispensed by pharmacies only with a prescription; although some outlets or online sellers may advertise sales without a receipt, obtaining prescription medicines without a prescription is unsafe and may be illegal.
- Verampil is used for hypertension, angina, supraventricular tachycardia, atrial fibrillation/flutter and migraine prophylaxis; it is a non‑dihydropyridine calcium channel blocker (phenylalkylamine) that inhibits L‑type calcium channels, reducing cardiac conduction, contractility and vascular smooth muscle tone.
- Usual dosage (adults): hypertension/angina 80–120 mg orally three times daily (immediate‑release) or 120–360 mg once daily (extended‑release); arrhythmia maintenance about 240–320 mg/day in divided doses; IV bolus for acute rhythm control 2.5–10 mg slow IV bolus (specialist dosing); paediatric dosing is weight‑based and specialist‑supervised.
- Form of administration: oral tablets (immediate‑release), extended‑release tablets/capsules, and intravenous solution (slow IV bolus).
- Onset time: oral immediate‑release typically begins within 30–60 minutes (peaks ~1–2 hours); extended‑release formulations have a slower onset; IV administration acts within minutes.
- Duration of action: oral immediate‑release about 4–6 hours; extended‑release preparations sustain effects up to 12–24 hours depending on formulation; IV effects last several hours depending on dose.
- Alcohol warning: avoid or limit alcohol while taking verampil — alcohol can increase dizziness and hypotension and worsen side effects.
- The most common side effec is constipation.
- Would you like to try verampil without a prescription? Please note verampil is prescription‑only and using it without medical supervision can be dangerous; I can help you find a safe, legal route to obtain and use it if needed.
Basic Verampil Information
- INN (International Nonproprietary Name): Verapamil
- Brand Names Available In Canada (English): Isoptin, Isoptin SR, generic Verapamil
- ATC Code: C08DA01
- Forms & Dosages: Tablets 40 mg, 80 mg, 120 mg; Extended‑Release 120 mg, 180 mg, 240 mg, 360 mg; ER Capsules 100–360 mg (varies by product); IV Solution 2.5 mg/mL in 2 mL or 5 mL ampoules.
- Manufacturers In Canada (English): Viatris (formerly Mylan), Teva Pharmaceuticals, Abbott (Isoptin), Pfizer (Calan), Gedeon Richter, Sanofi
- Registration Status In Canada (English): Approved by Health Canada
- OTC / Rx Classification: Prescription (Rx) only
Initial Instructions And Warnings For Canadian Patients
Verapamil is a prescription-only medicine in Canada and will have a Health Canada Drug Identification Number (DIN) on the package; keep the label for refills and reimbursement claims.
Bring an up-to-date medication list to every appointment or pharmacy visit, including over-the-counter products and supplements, because verapamil interacts with other heart medicines.
Store tablets and capsules below 25°C, in a dry place away from light.
IV ampoules (2 mL or 5 mL) are single‑use and must be discarded after opening.
If severe dizziness, fainting, a very slow pulse or chest pain occurs, seek emergency care immediately; overdose can cause severe hypotension or cardiac arrest.
Rural patients should confirm local pharmacy stock (Shoppers Drug Mart, Rexall, London Drugs) before travel and note that some brands use bilingual English/French labelling (for example Isoptin or Isoptin SR).
Everyday Use & Best Practices
Morning Vs Evening Dosing In Canadian Routines
Patients commonly ask whether to take verapamil in the morning or evening because routines help with adherence.
For immediate‑release dosing such as 80–120 mg three times daily, space doses roughly every eight hours to keep levels steady.
Extended‑release options, such as verapamil ER 120–360 mg, are usually taken once daily and are often scheduled for morning dosing to reduce the risk of nocturnal hypotension unless the prescriber advises night dosing.
Shift workers should set alarms or use pharmacist-prepared blister packs or med boxes available at Shoppers Drug Mart to maintain consistent verapamil dosing on variable schedules.
Taking With Or Without Meals (Canadian Diet Context)
Extended‑release products are formulated to reduce absorption variability and can be taken with or without food.
Immediate‑release tablets may be taken with a small amount of water and can be taken with breakfast such as toast and coffee; avoid taking them immediately after a large fatty meal if your prescriber has warned about variable absorption.
Practical reminders:
- Set dosing times tied to a routine meal or activity to improve adherence.
- Use phone alarms or pharmacy blister packs (30s/60s) when doses are multiple per day.
- Remember that ER is once daily while IR is typically three times daily.
- Check the DIN and formulation at each refill to ensure you have ER versus IR.
Safety Priorities
Who Should Avoid It (Health Canada Advisories)
Do not use verapamil in patients with severe hypotension (systolic blood pressure under 90 mmHg), advanced atrioventricular block or sick sinus syndrome unless a pacemaker is present.
Verapamil is contraindicated in cardiogenic shock and decompensated heart failure, and should be avoided with Wolff‑Parkinson‑White syndrome when atrial fibrillation is present.
Documented hypersensitivity to verapamil or excipients is an absolute contraindication.
Pregnant or breastfeeding patients should discuss risks and benefits with their prescriber because use is generally avoided unless benefits outweigh risks.
Always check the product monograph or DIN label at dispensing for the official Health Canada guidance.
Activities To Limit (Driving, Workplace Safety)
Dizziness, fatigue and bradycardia are common side effects that can impair driving or operation of machinery.
Avoid heavy machinery or safety‑sensitive tasks until you know how verapamil affects you.
If you have a safety‑sensitive job such as commercial driving or operating heavy equipment, inform occupational health or your employer before starting therapy.
Simple checklist before starting verapamil on a workday:
- Obtain a baseline blood pressure and pulse reading.
- Avoid starting the medication before a high‑risk shift or duty day.
- Report any syncope, near‑falls, or recurrent dizziness to your clinician immediately.
Dosage & Adjustments
General Regimen (DIN References)
Standard adult oral regimens include immediate‑release verapamil 80–120 mg taken three times daily for hypertension or angina.
Extended‑release options range from 120 mg to 360 mg once daily for smoother control and better adherence.
For maintenance of some supraventricular arrhythmias the total daily dose is commonly 240–320 mg given in divided doses.
Migraine prophylaxis dosing is typically 80–160 mg taken two to three times daily according to clinical response.
IV verapamil for acute rhythm conversion is given as a slow IV bolus of 2.5–10 mg in monitored settings; look for the product DIN and exact concentration on the dispensing label to confirm formulation and strength.
Special Cases (Elderly, Comorbidities)
Elderly patients are more sensitive to verapamil and should start at the lowest effective dose with slow titration and close monitoring of blood pressure and pulse.
Hepatic impairment requires dose reduction because verapamil is extensively metabolized in the liver.
Renal impairment usually does not require routine dose adjustment, but monitor for accumulation and adverse effects.
Pediatric use is specialist‑guided with weight‑based dosing for acute SVT and is not routine for chronic hypertension or angina in children.
User Testimonials
Positive Reports From Canadian Patients
Many Canadian patients report meaningful symptom relief on verapamil ER with fewer palpitations and better angina control.
Long‑term users also describe reduced migraine frequency when verapamil is used for prophylaxis, particularly with steady dosing schedules.
Rural patients often appreciate once‑daily ER formulations because they reduce the frequency of pharmacy trips.
Popular brands mentioned in Canadian forums include Isoptin and generics supplied by manufacturers such as Mylan or Teva.
Clear pharmacist counselling at community pharmacies like Shoppers Drug Mart or Rexall is commonly cited as helpful for adherence.
Common Challenges In Forums (Reddit Canada, Health Boards)
Constipation is one of the most frequently reported side effects and is often the reason patients switch agents.
Dizziness on standing and troublesome interactions when on other heart medications are common complaints on discussion boards.
Availability of specific brands or pack sizes (30, 60, 100) can vary regionally, creating frustration for some patients.
Practical peer tips often include increasing dietary fibre for constipation and checking pulse regularly to detect bradycardia early.
Remember that anecdotes are not clinical guidance; always confirm concerns with a pharmacist or prescriber.
Buying Guide
Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)
Verapamil products, including Isoptin and generics, are dispensed by community chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, as well as independent pharmacies.
Hospital IV formulations are supplied through acute‑care pharmacies for monitored administration.
Ask the dispensing pharmacist for the DIN and package size so you receive the correct formulation and strength (tablets, ER capsules, IV ampoules).
Price Comparison (In‑Store Vs Online, Cross‑Border Notes)
Prices vary by brand, strength and provincial coverage through programs such as Ontario Drug Benefit, BC PharmaCare and RAMQ.
Online Canadian pharmacies often match in‑store pricing and provide home delivery, and generic options from Teva or Viatris may be more affordable.
Cross‑border purchases from the U.S. can seem cheaper but introduce regulatory, customs and prescription transfer issues; ensure any product complies with Health Canada and has a DIN when possible.
In our online pharmacy, verampil is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
What’s Inside & How It Works
Ingredients Overview
The active ingredient in these products is verapamil, commonly supplied as verapamil hydrochloride in many formulations.
Typical tablet strengths are 40 mg, 80 mg and 120 mg, while ER capsules and tablets range from 120 mg to 360 mg.
Excipients vary by manufacturer and may include fillers, binders and tablet coatings; consult the package insert if you have known excipient allergies.
IV solutions are commonly 2.5 mg/mL supplied in 2 mL or 5 mL single‑use ampoules for acute care.
Mechanism Basics
Verapamil is a phenylalkylamine calcium‑channel blocker (ATC C08DA01) that reduces calcium influx into cardiac and vascular smooth muscle cells.
The result is slower atrioventricular nodal conduction, lower myocardial contractility and dilation of coronary and systemic arteries.
These pharmacologic effects make verapamil useful for supraventricular tachycardia, rate control in atrial fibrillation, angina and hypertension.
Compared with dihydropyridine agents like amlodipine or nifedipine, verapamil has more pronounced cardiac conduction effects and a higher incidence of constipation than some alternatives.
Main Indications
Approved Uses In Canada
Verapamil is approved for hypertension and angina and is indicated for certain supraventricular arrhythmias in adults.
Typical dosing for hypertension or angina with immediate‑release tablets is 80–120 mg three times daily, and ER formulations are commonly 120–360 mg once daily.
For arrhythmia maintenance, dosages often total 240–320 mg per day in divided doses.
IV formulation is used in monitored settings for acute rhythm conversion with slow boluses of 2.5–10 mg.
Off‑Label Uses By Canadian Physicians
Migraine prophylaxis is an off‑label use in some patients, commonly dosed at 80–160 mg two to three times daily depending on response and tolerability.
Pediatric applications are specialist‑driven, notably for acute SVT where IV verapamil or specialist oral dosing may be used with adjusted doses by weight.
Clinicians sometimes choose verapamil when AV nodal slowing is preferred and beta‑blockers are unsuitable or poorly tolerated.
Interaction Warnings
Food Interactions (Alcohol, Caffeine)
Alcohol can increase the risk of hypotension and dizziness when taken with verapamil, so advise moderation while on therapy.
Caffeine from coffee may change symptom perception such as palpitations but does not cause a major pharmacokinetic interaction with verapamil.
Avoid large amounts of grapefruit or grapefruit juice because grapefruit inhibits CYP3A4 and can raise verapamil blood levels.
Drug Conflicts (Health Canada Database)
Verapamil interacts with many cardiovascular medicines and CYP3A4 substrates or inhibitors.
Serious interactions include additive bradycardia and heart block with beta‑blockers, and increased digoxin levels when combined with verapamil; monitor digoxin concentrations and toxicity signs.
CYP3A4 inhibitors such as some macrolide antibiotics and antifungals can increase verapamil exposure and require monitoring and possible dose adjustment.
Several statins metabolized by CYP3A4 may be affected; check the Health Canada product monograph or pharmacy interaction database before starting new agents.
High‑risk co‑medications to review with patients include beta‑blockers, digoxin, certain macrolides and strong CYP3A4 inhibitors.
Latest Evidence & Insights
Verapamil continues to be a mainstay for AV‑nodal rate control and for angina and certain forms of hypertension in both Canadian and international practice.
Comparative trials often assess verapamil versus diltiazem for rate control and versus beta‑blockers for angina relief, with mixed differences in efficacy and tolerability across endpoints.
Evidence supports the use of ER formulations to improve adherence and provide smoother blood pressure control compared with immediate‑release dosing schedules.
IV verapamil remains effective for acute supraventricular tachycardia conversion in monitored settings when given as recommended boluses.
Clinical takeaways for Canadian practice include preferring ER products for patients with adherence challenges, monitoring liver function during long‑term therapy and reporting significant constipation or bradycardia to the prescriber.
Alternative Choices
When verapamil is unsuitable, there are several commonly used alternatives depending on the treatment goal and comorbidities.
Diltiazem is another non‑dihydropyridine calcium channel blocker with similar AV‑nodal effects and may be better tolerated for constipation in some patients.
Dihydropyridine agents such as amlodipine and nifedipine are effective for hypertension and angina but have less effect on cardiac conduction and can cause peripheral oedema.
Beta‑blockers like metoprolol or atenolol are effective for rate control and angina but require caution in asthma or COPD and can produce additive bradycardia when combined with verapamil.
Digoxin is an option for ventricular rate control in atrial fibrillation but requires careful monitoring because verapamil can increase digoxin levels.
Discuss with the prescriber the target symptom (rate control versus blood pressure versus angina), comorbid lung disease, constipation risk, potential drug interactions and formulary or cost considerations.
Regulation Snapshot
Health Canada approves verapamil products for prescription use and lists them with DINs on product labels.
Manufacturers supplying verapamil globally and in Canada include Viatris, Teva, Abbott (Isoptin) and Pfizer (Calan), among others.
Provincial formularies differ in which strengths or brands are listed and may require prior authorization for certain products under programs such as Ontario Drug Benefit, BC PharmaCare or RAMQ.
Packaging is commonly in blisters of 30, 50 or 100 tablets or ER bottles of 30 or 60 capsules, with IV ampoules typically in 2 mL or 5 mL single‑use vials.
Check the package at dispensing for the DIN, strength, manufacturer and bilingual labelling details, especially in Quebec and other bilingual regions.
FAQ
Can I Stop Verapamil Suddenly?
No, do not stop verapamil abruptly without medical advice because sudden withdrawal can worsen angina or precipitate arrhythmias.
Tapering should be performed under prescriber direction where indicated.
Will Verapamil Affect My Driving Or Work?
Yes, verapamil may cause dizziness, lightheadedness or bradycardia and can impair tasks that require alertness.
Avoid driving or safety‑sensitive activities until you understand how the medication affects you and report any near‑syncope to your clinician.
Is Verapamil Covered By Provincial Drug Plans?
Some formulations are covered under provincial plans such as ODB, BC PharmaCare and RAMQ depending on clinical criteria, age and income.
Pharmacists can check coverage using the DIN at dispensing and advise on generic options to reduce cost.
What Should I Do If I Miss A Dose?
Take the missed dose as soon as you remember unless it is almost time for the next dose, and never double up to catch up.
For once‑daily ER products, skip the missed dose if the next scheduled dose is near and resume the normal schedule the following day.
Guidelines For Proper Use
Confirm the indication, formulation and DIN at each refill and bring a current medication list to pharmacy pick‑up and clinical appointments.
Obtain baseline blood pressure, pulse and an ECG when recommended by your prescriber before starting verapamil, and check BP and pulse regularly during initiation and dose changes.
Report persistent constipation, dizziness, ankle swelling, syncope or symptoms suggesting bradycardia to a prescriber.
Long‑term therapy may warrant periodic liver function monitoring because verapamil is extensively metabolized by the liver.
Missed dose guidance: take as soon as remembered unless it is nearly time for the next dose; never double dose.
Overdose is a medical emergency; signs include severe hypotension, bradycardia or confusion and require emergency treatment such as IV fluids, vasopressors and calcium gluconate.
At the pharmacy pick‑up verify strength and brand, confirm dosing times, review interactions and consider blister packaging if adherence is a concern.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Halifax | Nova Scotia | 5-7 days |
| Victoria | British Columbia | 5-7 days |
| Saskatoon | Saskatchewan | 5-9 days |
| Regina | Saskatchewan | 5-9 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
| London | Ontario | 5-9 days |
| Kitchener | Ontario | 5-9 days |
| Charlottetown | Prince Edward Island | 5-9 days |